Intervention Review

Excitatory amino acid antagonists for acute stroke

  1. Keith W Muir1,*,
  2. Kennedy R Lees2

Editorial Group: Cochrane Stroke Group

Published Online: 21 JUL 2003

Assessed as up-to-date: 21 APR 2003

DOI: 10.1002/14651858.CD001244


How to Cite

Muir KW, Lees KR. Excitatory amino acid antagonists for acute stroke. Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD001244. DOI: 10.1002/14651858.CD001244.

Author Information

  1. 1

    Southern General Hospital, University Department of Neurology, Institute of Neurological Sciences, Glasgow, UK

  2. 2

    Western Infirmary, Glasgow, University Department of Medicine and Therapeutics, Glasgow, UK

*Keith W Muir, University Department of Neurology, Institute of Neurological Sciences, Southern General Hospital, 1345 Govan Road, Glasgow, G51 4TF, UK. k.muir@clinmed.gla.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JUL 2003

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Minoru Kawakami, Molecular Dissection of Cyclosporin A’s Neuroprotective Effect Reveals Potential Therapeutics for Ischemic Brain Injury, Brain Sciences, 2013, 3, 3, 1325

    CrossRef

  2. 2
    Michael D Hill, Renee H Martin, David Mikulis, John H Wong, Frank L Silver, Karel G terBrugge, Geneviève Milot, Wayne M Clark, R Loch MacDonald, Michael E Kelly, Melford Boulton, Ian Fleetwood, Cameron McDougall, Thorsteinn Gunnarsson, Michael Chow, Cheemun Lum, Robert Dodd, Julien Poublanc, Timo Krings, Andrew M Demchuk, Mayank Goyal, Roberta Anderson, Julie Bishop, David Garman, Michael Tymianski, Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial, The Lancet Neurology, 2012, 11, 11, 942

    CrossRef

  3. 3
    Lorraine V Kalia, Suneil K Kalia, Michael W Salter, NMDA receptors in clinical neurology: excitatory times ahead, The Lancet Neurology, 2008, 7, 8, 742

    CrossRef

  4. 4
    Paul A. Lapchak, Memantine, an uncompetitive low affinity NMDA open-channel antagonist improves clinical rating scores in a multiple infarct embolic stroke model in rabbits, Brain Research, 2006, 1088, 1, 141

    CrossRef

  5. 5
    Gabriel A. Silva, Nanotechnology approaches for the regeneration and neuroprotection of the central nervous system, Surgical Neurology, 2005, 63, 4, 301

    CrossRef

  6. 6
    Paul Bentley, Pankaj Sharma, Pharmacological treatment of ischemic stroke, Pharmacology & Therapeutics, 2005, 108, 3, 334

    CrossRef

  7. 7
    Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial, The Lancet, 2004, 363, 9407, 439

    CrossRef

  8. 8
    Gord Gubitz, Acute Stroke Manatement and Prevention of Recurrences,
  9. 9
    Lilia E Ziganshina, Tatyana Abakumova, Alexandra Kuchaeva, Cerebrolysin for acute ischaemic stroke, The Cochrane Library,
  10. 10
    Lilia E Ziganshina, Tatyana Abakumova, Alexandra Kuchaeva, Cerebrolysin for acute ischemic stroke, The Cochrane Library,
  11. 11
    Jia Liu, Lu-Ning Wang, Gamma aminobutyric acid (GABA) receptor agonists for acute stroke, The Cochrane Library,
  12. 12
    Jia Liu, Luning Wang, Gamma aminobutyric acid (GABA) receptor agonists for acute stroke, The Cochrane Library,
  13. 13
    Jia Liu, Lu-Ning Wang, Gamma aminobutyric acid (GABA) receptor agonists for acute stroke, The Cochrane Library,